Riccardo Paolo Camisasca
CIK: 0002151126
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ENTX
Entera Bio Ltd.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Camisasca Riccardo Paolo
Camisasca Riccardo Paolo (SEC CIK 0002151126) files insider reports with the SEC as Chief Medical Officer of Entera Bio Ltd. (ENTX).
Signal8 holds 1 ownership filing by Camisasca Riccardo Paolo, a Form 3, filed on Aug 21, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Camisasca Riccardo Paolo's filings is in JERUSALEM.
Other insiders filing for Entera Bio Ltd. (ENTX)
- Malca Yonatan, Director
- Taitel Haya, Director
- Ellis Sean, Director
- Yaacov-Garbeli Dana, Chief Financial Officer
- Galitzer Hillel, Chief Operating Officer
- Burshtein Gregory, Chief of R&D